Treatment for early syphilis and reactivity of serologic tests.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004917:Erythromycin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008431:Maternal-Fetal Exchange; D010401:Penicillin G Benzathine / Q000008:administration & dosage*; D010402:Penicillin G Procaine / Q000008:administration & dosage*; D010406:Penicillins / Q000009:adverse effects; D011247:Pregnancy; D013587:Syphilis / Q000188:drug therapy* / Q000276:immunology; D013588:Syphilis Serodiagnosis; D013752:Tetracycline / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D014209:Treponema Immobilization Test; D014210:Treponema pallidum / Q000187:drug effects
D000900:Anti-Bacterial Agents; D010406:Penicillins; D010402:Penicillin G Procaine; D004917:Erythromycin; D013752:Tetracycline; D010401:Penicillin G Benzathine